Chemotherapy-induced Nausea and Vomiting Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Chemotherapy-induced Nausea and Vomiting Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Chemotherapy-induced Nausea and Vomiting Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chemotherapy-induced Nausea and Vomiting Treatment Overall Market Size
2.1 Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size: 2024 VS 2032
2.2 Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chemotherapy-induced Nausea and Vomiting Treatment Players in Global Market
3.2 Top Global Chemotherapy-induced Nausea and Vomiting Treatment Companies Ranked by Revenue
3.3 Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue by Companies
3.4 Top 3 and Top 5 Chemotherapy-induced Nausea and Vomiting Treatment Companies in Global Market, by Revenue in 2024
3.5 Global Companies Chemotherapy-induced Nausea and Vomiting Treatment Product Type
3.6 Tier 1, Tier 2, and Tier 3 Chemotherapy-induced Nausea and Vomiting Treatment Players in Global Market
3.6.1 List of Global Tier 1 Chemotherapy-induced Nausea and Vomiting Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Chemotherapy-induced Nausea and Vomiting Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size Markets, 2024 & 2032
4.1.2 5-HT3 Inhibitors
4.1.3 NK1 Inhibitors
4.1.4 Other
4.2 Segmentation by Type - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue & Forecasts
4.2.1 Segmentation by Type - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2024 & 2032
5.1.2 Acute CINV
5.1.3 Delayed CINV
5.1.4 Breakthrough CINV
5.1.5 Others
5.2 Segmentation by Application - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue & Forecasts
5.2.1 Segmentation by Application - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2024 & 2032
6.2 By Region - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue & Forecasts
6.2.1 By Region - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2020-2025
6.2.2 By Region - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2026-2032
6.2.3 By Region - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2020-2032
6.3.2 United States Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.3.3 Canada Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.3.4 Mexico Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2020-2032
6.4.2 Germany Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.4.3 France Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.4.4 U.K. Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.4.5 Italy Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.4.6 Russia Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.4.7 Nordic Countries Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.4.8 Benelux Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2020-2032
6.5.2 China Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.5.3 Japan Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.5.4 South Korea Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.5.5 Southeast Asia Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.5.6 India Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2020-2032
6.6.2 Brazil Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.6.3 Argentina Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Revenue, 2020-2032
6.7.2 Turkey Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.7.3 Israel Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.7.4 Saudi Arabia Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
6.7.5 UAE Chemotherapy-induced Nausea and Vomiting Treatment Market Size, 2020-2032
7 Companies Profiles
7.1 Heron Therapeutics
7.1.1 Heron Therapeutics Corporate Summary
7.1.2 Heron Therapeutics Business Overview
7.1.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.1.4 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.1.5 Heron Therapeutics Key News & Latest Developments
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.2.4 Merck Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.2.5 Merck Key News & Latest Developments
7.3 Eisai
7.3.1 Eisai Corporate Summary
7.3.2 Eisai Business Overview
7.3.3 Eisai Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.3.4 Eisai Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.3.5 Eisai Key News & Latest Developments
7.4 Mundipharma
7.4.1 Mundipharma Corporate Summary
7.4.2 Mundipharma Business Overview
7.4.3 Mundipharma Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.4.4 Mundipharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.4.5 Mundipharma Key News & Latest Developments
7.5 Qilu Pharma
7.5.1 Qilu Pharma Corporate Summary
7.5.2 Qilu Pharma Business Overview
7.5.3 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.5.4 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.5.5 Qilu Pharma Key News & Latest Developments
7.6 Teva
7.6.1 Teva Corporate Summary
7.6.2 Teva Business Overview
7.6.3 Teva Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.6.4 Teva Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.6.5 Teva Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.7.4 Novartis Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.7.5 Novartis Key News & Latest Developments
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.8.4 Roche Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.8.5 Roche Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Corporate Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.9.4 Mylan Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.9.5 Mylan Key News & Latest Developments
7.10 Baxter
7.10.1 Baxter Corporate Summary
7.10.2 Baxter Business Overview
7.10.3 Baxter Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.10.4 Baxter Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.10.5 Baxter Key News & Latest Developments
7.11 GSK
7.11.1 GSK Corporate Summary
7.11.2 GSK Business Overview
7.11.3 GSK Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.11.4 GSK Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.11.5 GSK Key News & Latest Developments
7.12 Helsinn
7.12.1 Helsinn Corporate Summary
7.12.2 Helsinn Business Overview
7.12.3 Helsinn Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.12.4 Helsinn Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.12.5 Helsinn Key News & Latest Developments
7.13 Southwest Pharma
7.13.1 Southwest Pharma Corporate Summary
7.13.2 Southwest Pharma Business Overview
7.13.3 Southwest Pharma Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.13.4 Southwest Pharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.13.5 Southwest Pharma Key News & Latest Developments
7.14 Haisco
7.14.1 Haisco Corporate Summary
7.14.2 Haisco Business Overview
7.14.3 Haisco Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.14.4 Haisco Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.14.5 Haisco Key News & Latest Developments
7.15 Sun Pharma
7.15.1 Sun Pharma Corporate Summary
7.15.2 Sun Pharma Business Overview
7.15.3 Sun Pharma Chemotherapy-induced Nausea and Vomiting Treatment Major Product Offerings
7.15.4 Sun Pharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue in Global Market (2020-2025)
7.15.5 Sun Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Chemotherapy-induced Nausea and Vomiting Treatment Market Opportunities & Trends in Global Market
Table 2. Chemotherapy-induced Nausea and Vomiting Treatment Market Drivers in Global Market
Table 3. Chemotherapy-induced Nausea and Vomiting Treatment Market Restraints in Global Market
Table 4. Key Players of Chemotherapy-induced Nausea and Vomiting Treatment in Global Market
Table 5. Top Chemotherapy-induced Nausea and Vomiting Treatment Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Share by Companies, 2020-2025
Table 8. Global Companies Chemotherapy-induced Nausea and Vomiting Treatment Product Type
Table 9. List of Global Tier 1 Chemotherapy-induced Nausea and Vomiting Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotherapy-induced Nausea and Vomiting Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2026-2032
Table 30. Heron Therapeutics Corporate Summary
Table 31. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 32. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 33. Heron Therapeutics Key News & Latest Developments
Table 34. Merck Corporate Summary
Table 35. Merck Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 36. Merck Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 37. Merck Key News & Latest Developments
Table 38. Eisai Corporate Summary
Table 39. Eisai Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 40. Eisai Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 41. Eisai Key News & Latest Developments
Table 42. Mundipharma Corporate Summary
Table 43. Mundipharma Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 44. Mundipharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 45. Mundipharma Key News & Latest Developments
Table 46. Qilu Pharma Corporate Summary
Table 47. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 48. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 49. Qilu Pharma Key News & Latest Developments
Table 50. Teva Corporate Summary
Table 51. Teva Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 52. Teva Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 53. Teva Key News & Latest Developments
Table 54. Novartis Corporate Summary
Table 55. Novartis Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 56. Novartis Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 57. Novartis Key News & Latest Developments
Table 58. Roche Corporate Summary
Table 59. Roche Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 60. Roche Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 61. Roche Key News & Latest Developments
Table 62. Mylan Corporate Summary
Table 63. Mylan Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 64. Mylan Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 65. Mylan Key News & Latest Developments
Table 66. Baxter Corporate Summary
Table 67. Baxter Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 68. Baxter Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 69. Baxter Key News & Latest Developments
Table 70. GSK Corporate Summary
Table 71. GSK Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 72. GSK Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 73. GSK Key News & Latest Developments
Table 74. Helsinn Corporate Summary
Table 75. Helsinn Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 76. Helsinn Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 77. Helsinn Key News & Latest Developments
Table 78. Southwest Pharma Corporate Summary
Table 79. Southwest Pharma Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 80. Southwest Pharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 81. Southwest Pharma Key News & Latest Developments
Table 82. Haisco Corporate Summary
Table 83. Haisco Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 84. Haisco Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 85. Haisco Key News & Latest Developments
Table 86. Sun Pharma Corporate Summary
Table 87. Sun Pharma Chemotherapy-induced Nausea and Vomiting Treatment Product Offerings
Table 88. Sun Pharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue (US$, Mn) & (2020-2025)
Table 89. Sun Pharma Key News & Latest Developments
List of Figures
Figure 1. Chemotherapy-induced Nausea and Vomiting Treatment Product Picture
Figure 2. Chemotherapy-induced Nausea and Vomiting Treatment Segment by Type in 2024
Figure 3. Chemotherapy-induced Nausea and Vomiting Treatment Segment by Application in 2024
Figure 4. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Chemotherapy-induced Nausea and Vomiting Treatment Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Chemotherapy-induced Nausea and Vomiting Treatment Revenue in 2024
Figure 9. Segmentation by Type � Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
Figure 13. By Region - Global Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
Figure 14. By Country - North America Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
Figure 15. United States Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
Figure 19. Germany Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 20. France Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
Figure 27. China Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 31. India Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
Figure 33. Brazil Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Chemotherapy-induced Nausea and Vomiting Treatment Revenue Market Share, 2020-2032
Figure 36. Turkey Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Chemotherapy-induced Nausea and Vomiting Treatment Revenue, (US$, Mn), 2020-2032
Figure 40. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Merck Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Eisai Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Mundipharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Teva Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Novartis Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Roche Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Mylan Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Baxter Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. GSK Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Helsinn Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Southwest Pharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Haisco Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Sun Pharma Chemotherapy-induced Nausea and Vomiting Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
